Thomson Reuters names eight Keystone Law partners in its Stand-out Lawyers Guide 2026
Andrea James, Andrew Darwin & Anna McKibbin
An accomplished regulatory life sciences expert, Paul has 30 years’ experience and expert knowledge of the regulatory, commercial, intellectual property, and product liability needs of the pharmaceutical, biotechnology, and medical device sectors on an international and domestic scale. Clients have included leading pharmaceutical companies such as Smith Kline Beecham.
Paul advises on the regulatory, commercial, intellectual property and product liability needs of the pharmaceutical, biotechnology, and medical device sectors on an international and domestic scale.
Experience
Please note: The experience list above may include examples of work completed prior to joining Keystone Law.
Recognised by Best Lawyers (UK) for Life Sciences Law 2020–2025
Recognised by The Legal 500 for Corporate and Commercial: Venture Capital 2023
“At the ‘excellent’ Keystone Law, commercial and regulatory lawyer Paul Ransom joined from Pinsent Masons LLP in May 2015”
The Legal 500 2016
“Keystone Law made several hires in 2015, including life sciences expert Paul Ranson, who moved from Pinsent Masons LLP.”
The Legal 500 2016
“Life sciences specialist Paul Ranson is esteemed for his skills on commercial transactions and also for his magisterial knowledge of the regulatory environment affecting companies in the sector.”
Chambers UK 2015
“Paul Ranson focuses his practice on regulatory matters for a variety of pharmaceutical and biotech firms. He recently advised Alliance Pharma on its acquisition of Opus Group Holdings.”
Chambers UK 2014
Paul qualified as a solicitor in 1986 and as a barrister in 1975. Prior to joining Keystone Law in 2015, he worked at the following firms: